AstraZeneca to invest $2.5bn in China after scandal
London-listed drugmaker will establish research centre in Beijing
Full Article
AstraZeneca to invest $2.5bn in China after scandal
FT.com
0 shares
1 views
You might like
Related news coverage
Singapore’s DBS courts rich Chinese with wealth manager hiring spree
Expansion comes as other banks grow wary of customers from China after S$3bn money-laundering scandal
FT.com